The latter is reportedly up-regulated and activated by PI3K-mTOR inhibition in breast and pancreatic cancer, with data supporting efficacy of combined inhibition of PI3K-mTOR and Notch [64, 65]. The gene discussed is PIK3CD; the disease is familial pancreatic carcinoma.